Physician profile
John G Finkenberg
NPI 1285703413
$20,348.19
in general payments reported to CMS, 2019-2025
21 companies · $18K in 2025
The $18K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $987 · 2020: $1,261 · 2021: $150 · 2022: $52.11 · 2023: $127 · 2024: $86.18 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Travel and Lodging: $2,626 · Food and Beverage: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,812.50 |
| Travel and Lodging | $2,626.29 |
| Food and Beverage | $458.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ebi, LLC | $15,177.50 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System, Spf Xl Iib Implantable Spinal Fusion Stimulator, Biomet Ebi Bone Healing System |
| Zimmer Biomet Holdings, INC. | $1,820.03 | 2019-2020 | |
| Djo, LLC | $1,771.29 | 2025 | Cmf, Chattanooga |
| Highridge Medical LLC | $490.00 | 2025 | Biomet Ebi Bone Healing System, Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Depuy Synthes Sales INC. | $243.14 | 2019-2025 | Milagro, Healix Knotless Peek, Truespan Orthocord |
| Si-Bone, INC. | $141.94 | 2019 | |
| Carlsmed, INC. | $134.22 | 2025 | Aprevo |
| Davol INC. | $86.35 | 2025 | Arista |
| Globus Medical, INC. | $85.80 | 2023 | Clavicular Fracture Fixation, Proximal Humerus Strut |
| Stryker Corporation | $84.97 | 2021-2024 | Gamma |
| Smith+Nephew, INC. | $59.42 | 2021-2022 | |
| Pacira Therapeutics, INC. | $40.99 | 2019-2021 | |
| Integra Lifesciences Corporation | $35.30 | 2021 | |
| Nevro Corp. | $32.33 | 2022 | |
| Boston Scientific Corporation | $27.94 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $23.87 | 2021 | |
| Medtronic USA, INC. | $22.32 | 2019 | |
| Acera Surgical, INC. | $21.65 | 2023 | Restrata Wound Matrix |
| Kerecis Limited | $19.37 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Bioventus LLC | $16.72 | 2024 | Durolane |
| Ermi LLC | $13.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Finkenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.